Tubular
AKI
IKKβ
NF-ĸB
tissue regeneration
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Sep 2022
05 Sep 2022
Historique:
received:
06
07
2022
revised:
01
09
2022
accepted:
02
09
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Acute kidney injury (AKI) is a common renal injury leading to relevant morbidity and mortality worldwide. Most of the clinical cases of AKI are caused by ischemia reperfusion (I/R) injury with renal ischemia injury followed by reperfusion injury and activation of the innate immune response converging to NF-ĸB pathway induction. Despite the clear role of NF-ĸB in inflammation, it has recently been acknowledged that NF-ĸB may impact other cell functions. To identify NF-ĸB function with respect to metabolism, vascular function and oxidative stress after I/R injury and to decipher in detail the underlying mechanism, we generated a transgenic mouse model with targeted deletion of IKKβ along the tubule and applied I/R injury followed by its analysis after 2 and 14 days after I/R injury. Tubular IKKβ deletion ameliorated renal function and reduced tissue damage. RNAseq data together with immunohistochemical, biochemical and morphometric analysis demonstrated an ameliorated vascular organization and mRNA expression profile for increased angiogenesis in mice with tubular IKKβ deletion at 2 days after I/R injury. RNAseq and protein analysis indicate an ameliorated metabolism, oxidative species handling and timely-adapted cell proliferation and apoptosis as well as reduced fibrosis in mice with tubular IKKβ deletion at 14 days after I/R injury. In conclusion, mice with tubular IKKβ deletion upon I/R injury display improved renal function and reduced tissue damage and fibrosis in association with improved vascularization, metabolism, reactive species disposal and fine-tuned cell proliferation.
Identifiants
pubmed: 36077596
pii: ijms231710199
doi: 10.3390/ijms231710199
pmc: PMC9456401
pii:
doi:
Substances chimiques
NF-kappa B
0
I-kappa B Kinase
EC 2.7.11.10
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC 877
Organisme : ImmUniverse
ID : 853995
Organisme : BIOMAP
ID : 821511
Organisme : Deutsche Forschungsgemeinschaft
ID : FOR 5042
Organisme : Helmut Horten Stiftung
ID : x
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
Am J Physiol Renal Physiol. 2009 Apr;296(4):F902-11
pubmed: 19193726
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Vet Comp Oncol. 2021 Sep;19(3):551-566
pubmed: 33759339
Curr Transplant Rep. 2014 Sep 1;1(3):147-154
pubmed: 25419507
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1922-1929
pubmed: 28903970
PLoS One. 2020 Jun 3;15(6):e0234038
pubmed: 32492075
Kidney Dis (Basel). 2015 May;1(1):80-9
pubmed: 27536668
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F1005-F1014
pubmed: 27582100
Nat Methods. 2013 Apr;10(4):325-7
pubmed: 23435259
Clin Invest Med. 2020 Aug 29;43(3):E33-43
pubmed: 32971583
Onco Targets Ther. 2021 Jan 25;14:667-682
pubmed: 33531815
Exp Mol Pathol. 2016 Apr;100(2):344-52
pubmed: 26970279
Front Immunol. 2019 Apr 16;10:815
pubmed: 31040851
Int J Mol Sci. 2021 Jan 14;22(2):
pubmed: 33466673
Am J Hypertens. 2011 Sep;24(9):999-1006
pubmed: 21677697
J Am Soc Nephrol. 2016 Sep;27(9):2658-69
pubmed: 26823548
FASEB Bioadv. 2020 Dec 30;3(2):94-107
pubmed: 33615154
Front Med (Lausanne). 2021 Nov 29;8:744122
pubmed: 34912819
Oncotarget. 2016 Feb 16;7(7):7856-65
pubmed: 26760963
Nephron Exp Nephrol. 2010;115(3):e33-7
pubmed: 20424481
Clin Exp Pharmacol Physiol. 2021 Oct;48(10):1391-1401
pubmed: 34152603
Histochem Cell Biol. 1998 Jan;109(1):75-86
pubmed: 9452958
Biochem Biophys Res Commun. 2021 May 21;554:99-106
pubmed: 33784512
J Am Soc Nephrol. 2007 Jun;18(6):1824-34
pubmed: 17460141
Nat Rev Nephrol. 2014 Apr;10(4):193-207
pubmed: 24445744
J Gastroenterol Hepatol. 2021 Jan;36(1):196-203
pubmed: 32537806
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Mol Cells. 2019 Dec 31;42(12):893-905
pubmed: 31822044
Nat Med. 2008 Sep;14(9):979-84
pubmed: 18724376
FASEB J. 2022 Sep;36(9):e22512
pubmed: 36001064
Eur J Clin Invest. 2021 Jul;51(7):e13539
pubmed: 33729579
Trends Cell Biol. 2021 Mar;31(3):166-178
pubmed: 33422358
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
BMC Bioinformatics. 2016 Oct 21;17(1):428
pubmed: 27769170
Genes Dev. 2016 Aug 15;30(16):1837-51
pubmed: 27585591
Mol Med Rep. 2022 Jun;25(6):
pubmed: 35506437
Int Urol Nephrol. 2022 Jun;54(6):1311-1321
pubmed: 34633599
Acta Physiol (Oxf). 2018 Feb;222(2):
pubmed: 28656611
Kidney Int. 2021 Jul;100(1):67-78
pubmed: 33831367
Acta Physiol (Oxf). 2021 Jan;231(1):e13492
pubmed: 32419327
J Am Soc Nephrol. 2021 Sep;32(9):2117-2124
pubmed: 34108233
Am J Pathol. 2011 Nov;179(5):2177-88
pubmed: 21925138
Exp Ther Med. 2016 Jul;12(1):377-383
pubmed: 27347065
Nephrol Dial Transplant. 2022 Jul 26;37(8):1417-1425
pubmed: 33247734
Nat Rev Nephrol. 2021 Aug;17(8):513-527
pubmed: 33879883
Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F471-84
pubmed: 25007874
Nat Metab. 2020 Aug;2(8):732-743
pubmed: 32694833